Analyst Ratings February 3, 2026

Truist Stays Bullish on Palantir, Boosts Long-Term Forecasts Amid AI-Driven Momentum

Analyst reiterates Buy and $223 price target as revenue and margins surge; mixed analyst views reflect optimism tempered by valuation and multiple-compression concerns

By Marcus Reed PLTR
Truist Stays Bullish on Palantir, Boosts Long-Term Forecasts Amid AI-Driven Momentum
PLTR

Truist Securities has reaffirmed a Buy rating on Palantir Technologies Inc. (PLTR) and set a $223 price target, citing the company’s accelerating revenue growth and strong margin profile as evidence that Palantir is driving AI adoption at scale. The firm materially raised its 2026 revenue and free cash flow forecasts, while other analysts offered a range of reactions from raised targets to lowered estimates and Neutral stances. Market data indicates the stock is trading well above its Fair Value, and analysts point to both capacity signals and valuation risks as key considerations.

Key Points

  • Truist Securities reiterates Buy for PLTR with a $223 price target, citing strong AI-driven revenue acceleration and high gross margins - impacts technology and enterprise software sectors.
  • Truist raised 2026 revenue and free cash flow estimates by more than $1 billion each, with both projections now above Palantir’s guidance ranges - relevant to capital markets and corporate earnings expectations.
  • Analyst reactions vary: some firms raised targets and maintained Overweight/Outperform stances while others cut targets or maintained Neutral ratings, reflecting mixed views on valuation and multiple compression - affects investor sentiment and equity markets.

Truist Securities has reiterated a Buy rating on Palantir Technologies Inc. (NASDAQ:PLTR), maintaining a price target of $223.00 as it points to what the firm calls a clear leadership position in AI-driven enterprise software. The analyst note frames Palantir as an "AI pure-play victor," citing a sequence of accelerating revenue gains and strong profitability metrics.

The research firm emphasized Palantir’s most robust quarter since becoming a public company, with revenue growth accelerating for the tenth consecutive quarter to 70% year-over-year on an annual revenue run rate that exceeds $4 billion. Truist highlighted that the company’s trailing-12-month revenue rose by 47.23% and that Palantir reported an outstanding gross profit margin of 80.81%.

Based on the recent results, Truist materially increased its 2026 revenue and free cash flow estimates by more than $1 billion each. Those revised projections now sit above the guidance ranges Palantir provided. The research note references InvestingPro data indicating that Palantir has been producing strong cash returns, and it says analysts expect continued sales growth during the current year.

Truist pointed to several operating indicators that support its optimistic outlook. Remaining performance obligations were up 188% year-over-year, and U.S. Commercial Remaining Deal Value rose 145% year-over-year. Management commentary, the firm noted, suggests that demand in the U.S. remains stronger than supply. On the balance-sheet side, Palantir’s current ratio of 6.43 was highlighted as a sign that liquid assets substantially exceed short-term liabilities.

Palantir’s most recent quarterly report matched the upbeat tone: fourth-quarter results came in about 5% ahead of expectations overall, including a 6% increase in U.S. commercial revenue. Margin expansion featured prominently in analyst read-throughs. Cantor Fitzgerald referenced a "Rule of 127%," and Piper Sandler called attention to a 70% revenue increase alongside 57% EBIT margins, which together produced a Rule of 40 score of 127%.

Not all analyst reactions were identical. DA Davidson reduced its price target to $180 while keeping a Neutral rating, citing accelerating revenue growth tied to U.S. demand for AI solutions. Mizuho adjusted its target down to $195, noting concerns about what it described as "significant comp multiple compression," even as it called the reported results "fantastic." Wedbush retained an Outperform rating with a $230 target, praising the results for exceeding expectations across multiple metrics.

Further positioning by other firms included Cantor Fitzgerald reiterating a Neutral rating with a $198 price target and Piper Sandler raising its target to $230 while maintaining an Overweight stance. The collection of analyst notes reflects a mix of optimism about Palantir’s AI-driven growth and caution about valuation and multiple dynamics.

Separately, market valuation context was noted: InvestingPro data suggests Palantir’s shares are trading well above the platform’s Fair Value estimate. That observation sits alongside the divergent analyst targets and underscores a tension between operational momentum and current market pricing.


Conclusion

Truist’s reaffirmation of a Buy rating and its upgraded long-term forecasts signal conviction in Palantir’s ability to convert AI demand into accelerating revenue and strong cash flow. At the same time, mixed responses from other brokerages and an InvestingPro-derived indicator that the stock is trading above Fair Value illustrate continuing debate over valuation and the sustainability of the multiple expansion that has accompanied recent results.

Risks

  • Palantir’s shares are trading well above InvestingPro’s Fair Value estimate, indicating valuation risk for investors - affects equity markets and technology sector allocation.
  • Some brokers lowered price targets or cited concerns over "significant comp multiple compression," signaling potential downward pressure on the stock multiple - impacts investor returns in the technology sector.
  • Management commentary indicating U.S. demand outstripping supply suggests potential capacity or execution constraints that could affect near-term delivery and revenue conversion - relevant to enterprise customers and software service delivery.

More from Analyst Ratings

Freedom Capital Upholds Sell on ExxonMobil, Keeps $123 Target Despite Strong Ops Feb 3, 2026 Freedom Capital Keeps Buy on Flexsteel After Strong Q2; $54 Price Target Intact Feb 3, 2026 UBS Lifts ExxonMobil Price Target to $171 After Q4 Results Amid Operational Headwinds Feb 3, 2026 UBS Stays Bullish on Tenet as Conifer Ownership and Contract Terms Shift Feb 3, 2026 UBS Sticks With Neutral on Crocs as Market Sentiment Skews Bearish Feb 3, 2026